Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?

Autor: Carolin Hoffmann, Mario Losen, Peter C. M. Molenaar, Shenghua Zong, Marina Mané-Damas, Pilar Martinez-Martinez
Přispěvatelé: Promovendi MHN, Psychiatrie & Neuropsychologie, RS: MHeNs - R3 - Neuroscience, RS: MHeNs - R2 - Mental Health
Rok vydání: 2017
Předmět:
lcsh:Immunologic diseases. Allergy
0301 basic medicine
GLUTAMATE-RECEPTOR
neurotransmitter receptor
Population
Immunology
Disease
Review
blood–brain barrier
Pathogenesis
03 medical and health sciences
0302 clinical medicine
Neurotransmitter receptor
medicine
Immunology and Allergy
pathogenicity
LIMBIC ENCEPHALITIS
SYSTEMIC-LUPUS-ERYTHEMATOSUS
education
MYASTHENIA-GRAVIS
Depression (differential diagnoses)
education.field_of_study
business.industry
AMPA RECEPTOR
Limbic encephalitis
CENTRAL-NERVOUS-SYSTEM
Autoantibody
ANTI-NMDAR ENCEPHALITIS
blood-brain barrier
medicine.disease
DOPAMINE D2 RECEPTOR
D-ASPARTATE RECEPTOR
neuronal surface autoantibodies
neuropsychiatric disorders
030104 developmental biology
Schizophrenia
depression
ion channel
immuno-globulin
COMPLEMENT-MEDIATED CYTOTOXICITY
lcsh:RC581-607
business
immunoglobulin
030217 neurology & neurosurgery
Zdroj: Frontiers in Immunology
Frontiers in Immunology, 8:752. Frontiers Media S.A.
Frontiers in Immunology, Vol 8 (2017)
ISSN: 1664-3224
Popis: Autoimmune diseases are affecting around 7.6-9.4% of the general population. A number of central nervous system disorders, including encephalitis and severe psychiatric disorders have been demonstrated to associate with specific neuronal surface autoantibodies. It has become clear that specific autoantibodies targeting neuronal surface antigens and ion channels could cause severe mental disturbances. A number of studies have focused or are currently investigating the presence of autoantibodies in specific mental conditions such as schizophrenia and bipolar disorders. However, less is known about other conditions such as depression. Depression is a psychiatric disorder with complex etiology and pathogenesis. The diagnoses criteria of depression are largely based on symptoms but not on the origin of the disease. The question which arises is whether in a subgroup of patients with depression, the symptoms might be caused by autoantibodies targeting membrane associated antigens. Here, we describe how autoantibodies targeting membrane proteins and ion channels cause pathological effects. We discuss the physiology of these antigens and their pathogenicity in relation to depression. Finally, we summarize a number of studies detecting neuronal surface autoantibodies with a special focus on those that the cohorts include depression diagnosis and/ or show depressive symptoms.
Databáze: OpenAIRE